AI Science Tracker
EN

Boosted models classify INR-defined coagulopathy after brain injury

Huizhou Municipal Central Hospital · 31 Jan 2026 · medicine

Discovery

Boosted models classify INR-defined coagulopathy after brain injury

Source check: Source checked. Not independent scientific confirmation.

Finding: A glmBoost/gradient-boosting model classified INR-defined coagulopathy in older adults with traumatic brain injury, using 484 MIMIC-IV and 788 eICU records. The primary figure reports AUC 0.901 in derivation data and 0.701 in eICU. Both cohorts influenced model selection, so the latter is not an independent validation estimate. Timing, imputation and inconsistent narrative reporting limit interpretation; the study does not establish early warning or benefit from treatment changes.

Technology: glmBoost feature selection; gradient boosting machine

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
glmBoost selects clinical/laboratory features, then a gradient boosting machine learns their relationship with the recorded INR-based coagulation label.
Test and result
Retrospective classification against INR greater than 1.2 using clinical/laboratory features. Figure 3 identifies 13 selected variables and reported AUC .901/.701 in the two datasets; the model was chosen using average performance across both cohorts.
Limitation / still unknown
Independent validation, prediction before coagulopathy and clinical benefit remain unestablished. Data extraction/imputation includes incompletely specified hospitalization timing. Text gives inconsistent average AUC/variable counts; the quoted cohort AUCs are explicitly those in the primary figure and corresponding Discussion.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12858556/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant cohort/reference, imputation/model-selection Methods, Results, actual Figure3 and limitations. Supplementary-file endpoint timed out; no supplementary table review claimed. Exact primary identity/date and fresh primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.